Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension

Journal of Applied Physiology

Volumn 83, Issue 6, 1997, Pages 1968-1975

  Brilli, Richard J ^a   Krafte Jacobs, Brian ^a   Smith, Daniel J ^b   Roselle, Dominick ^b   Passerini, Daniel ^b   Vromen, Amos ^a   Moore, Lori ^a   Szabo, Csaba ^a   Salzman, Andrew L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF AKRON   (United States)

Author keywords

Nitric oxide donor; Pulmonary hypertension

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 (DIMETHYLAMINO)ETHYLPUTREANINE NONOATE; ETHYLPUTREANINE NONOATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; THROMBOXANE RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; INTRATRACHEAL DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STEADY STATE; SWINE; VASCULAR RESISTANCE;

EID: 0031468321     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1997.83.6.1968     Document Type: Article

References (50)

1. Abman, S. H., J. L. Griebel, D. K. Parker, J. M. Schmidt, D. S. Swanton, and J. P. Kinsella. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J. Pediatr. 124: 881-884, 1994.
2. Beghetti, M., W. Habre, B. Friedli, and M. Berner. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br. Heart J. 73: 65-68, 1995.
3. Betit, P., I. Adatia, P. Benjamin, J. E. Thompson, and D. L. Wessel. Inhaled nitric oxide: evaluation of a continuous titration delivery technique for infant and manual ventilation. Respir. Care 40: 706-715, 1995.
4. Cohen, S. S. What do polyamines do? Nature 274: 209-214, 1978.
5. Day, R. W., M. Guarin, J. M. Lynch, D. D. Vernon, and J. M. Dean. Inhaled nitric oxide in children with severe lung disease: results of acute and prolonged therapy with two concentrations. Crit. Care Med. 24: 215-221, 1996.
6. Diodati, J. G., A. A. Quyyumi, and L. K. Keefer. Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: hemodynamic effect in the rabbit. J. Cardiovasc. Pharmacol. 22: 287-292, 1993.
7. Disalvo, E. Permeability of water and polar solutes in lipid bilayers. Adv. Colloid Interface Sci. 29: 141-170, 1988.
8. Etches, P., K. Finer, A. Barrington, A. Graham, and W. Chan. Nitric oxide reverses acute hypoxic pulmonary hypertension in the newborn piglet. Pediatr. Res. 35: 15-19, 1994.
9. Frampton, M. W., P. E. Morrow, C. Cox, R. Gibb, D. M. Speers, and M. J. Utell. Effects of nitrogen dioxide on pulmonary function and airway reactivity in normal humans. Am. Rev. Respir. Dis. 143: 522-527, 1991.
10. Frostell, C. G., H. Blomqvist, G. Hedenstierna, J. Lundberg, and W. M. Zapol. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 78: 427-435, 1993.
11. Goldman, A. P., R. C. Tasker, S. G. Haworth, P. E. Sigston, and D. J. Macrae. Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 98: 708-713, 1996.
12. Gong, H. Health effects of air pollution. A review of clinical studies. Clin. Chest Med. 13: 201-214, 1992.
13. Hampl, V., M. Tristani-Firouzi, T. C. Hutsell, and S. L. Archer. Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension. Cardiovasc. Res. 31: 55-62, 1996.
14. Hess, D., L. Bigatello, R. Kacmarek, R. Ritz, C. A. Head, and W. E. Hurford. Use of inhaled nitric oxide in patients with acute respiratory distress syndrome. Respir. Care 41: 424-446, 1996.
15. Hess, D., R. M. Kacmarek, R. Ritz, L. M. Bigatello, and W. E. Hurford. Inhaled nitric oxide delivery systems: a role for respiratory therapists. Respir. Care 40: 702-705, 1995.
16. Journois, D., P. Rouard, P. Mauriat, T. Malhere, P. Vouhe, and D. Safran. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J. Thorac. Cardiovasc. Surg. 107: 1129-1135, 1994.
17. Katz, R., M. Pollack, and D. Spady. Cardiopulmonary abnormalities in severe acute respiratory failure. J. Pediatr. 104: 357-364, 1984.
18. Kiff, R. J., D. W. Moss, and S. Moncada. Effect of nitric oxide gas on the generation of nitric oxide by isolated blood vessels: implication for inhalation therapy. Br. J. Pharmacol. 113: 496-498, 1994.
19. Kinsella, J. P., and S. H. Abman. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J. Pediatr. 126: 853-864, 1995.
20. Kinsella, J. P., J. A. McQueston, A. A. Rosenberg, and S. H. Abman. Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H875-H880, 1992.
21. Kinsella, J. P., W. H. Toews, D. Henry, and S. Abman. Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension. J. Pediatr. 122: 803-806, 1993.
22. Maragos, C. M., D. Morley, D. A. Wink, T. M. Dunams, J. E. Saavedra, A. Hoffman, A. A. Bove, L. Isaac, and L. K. Keefer. Complexes of NO with nucleophiles as agents for the controlled release of nitric oxide. Vasorelaxant effects. J. Med. Chem. 34: 3242-3247, 1991.
23. Miller, O. I., S. F. Tang, A. Keech, and D. S. Celermajer. Rebound pulmonary hypertension on withdrawl from inhaled nitric oxide (letter). Lancet 346: 51-52, 1995.
24. Moncada, S., R. M. J. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-141, 1991.
25. Morley, D., and L. K. Keefer. Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J. Cardiovasc. Pharmacol. 22: S3-S9, 1993.
26. Morley, D., C. M. Maragos, X. Y. Zhang, M. Boignon, D. A. Wink, and L. K. Keefer. Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators. J. Cardiovasc. Pharmacol. 21: 670-676, 1993.
27. National Institute of Occupational Safety Hazards. Recommendations for occupational safety and health standards. MMWR Morb. Mortal. Wkly. Rep. 37: 1-29, 1988.
28. Nelin, L., C. Moshin, T. Sasidharan, and C. Dawson. The effect of inhaled nitric oxide on the pulmonary circulation of the neonatal pig. Pediatr. Res. 35: 20-24, 1994.
29. Nishimura, M., D. Hess, and R. M. Kacmarek, R. Ritz, and W. E. Hurford. Nitrogen dioxide production during mechanical ventilation with nitric oxide in adults. Effects of ventilator internal volume, air versus nitrogen dilution, minute ventilation, and inspired oxygen fraction. Anesthesiology 82: 1246-1254, 1995.
30. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
31. Paula, S., A. Volkov, A. Van Hoek, T. H. Haines, and D. W. Deamer. Permeation of protons, potassium ions, and small polar molecules through phospholipid bilayers as a function of membrane thickness. Biophys. J. 70: 339-348, 1996.
32. Peck, K., A. Ghanem, and W. Higuchi. Hindered diffusion of polar molecules through and effective pore radii estimates of intact and ethanol treated human epidermal membrane. Pharmacol. Res. 11: 1306-1314, 1994.
33. Pohl, V., J. Holtz, and R. Busse. Crucial role of the endothelium in the vasodilator response to increased flow in vivo. Hypertension 8: 37-44, 1986.
34. Radermacher, P., P. Santak, H. Becker, and K. J. Falke. Prostaglandin E1 and nitroglycerin reduce pulmonary capillary pressure but worsen V/Q distribution in patients with adult respiratory distress syndrome. Anesthesiology 70: 601-609, 1989.
35. 2 exposure on alveolar permeability and glutathione peroxidase in healthy humans. Am. Rev. Respir. Dis. 146: 654-659, 1992.
36. Rimar, S., and C. N. Gillis. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 88: 2884-2887, 1993.
37. Rimar, S., and N. Gillis. Site of pulmonary vasodilation by inhaled nitric oxide in the perfused lung. J. Appl. Physiol. 78: 1745-1749, 1995.
38. Roberts, J. D., T. Y. Chen, N. Kawai, J. Wain, P. Dupuy, A. Shimouchi, K. Bloch, D. Polaner, and W. Zapol. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ. Res. 72: 246-254, 1993.
39. Roberts, J. D., P. Lang, L. M. Bigatello, G. J. Vlahakes, and W. M. Zapol. Inhaled nitric oxide in congenital heart disease. Circulation 87: 447-453, 1993.
40. Rossaint, R., K. J. Falke, F. Lopez, K. Slama, U. Pison, and W. M. Zapol. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328: 399-405, 1993.
41. Rossaint, R., H. Gerlach, H. Schmidt-Ruhnke, D. Pappert, K. Lewandowski, W. Steudel, and K. Falke. Efficacy inhaled nitric oxide in patients with severe ARDS. Chest 107: 1107-1115, 1995.
42. Rubanyi, G. M., J. C. Romero, and P. M. Vanhoutte. Flow-induced release of endothelium-derived relaxing factor. Am. J. Physiol. 250 (Heart Circ. Physiol. 19): H1145-H1149, 1986.
43. Stenqvist, O., B. Kjelltoft, and S. Lundin. Evaluation of a new system for ventilatory administration of nitric oxide. Acta Anaesthesiol. Scand. 37: 687-691, 1993.
44. Stephens, R. J., G. Freeman, and M. J. Evans. Early response of lungs to low levels of nitrogen dioxide. Light and electron microscopy. Arch. Environ. Health 24: 160-179, 1972.
45. Theodore, J., E. D. Robin, R. Gaudio, and J. Acevedo. Transalveolar transport of large polar solutes (sucrose, inulin, and dextran). Am. J. Physiol. 229: 989-996, 1975.
46. Vanderford, P. A., J. Wong, R. Chang, L. K. Keefer, S. J. Soifer, and J. R. Fineman. Diethylamine/nitric oxide (NO) adduct, an NO donor, produces potent pulmonary and systemic vasodilation in intact newborn lambs. J. Cardiovasc. Pharmacol. 23: 113-119, 1994.
47. Wessel, D. L., I. Adatia, J. E. Thompson, and P. R. Hickey. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit. Care Med. 22: 930-938, 1994.
48. Winberg, P., B. Lundell, and L. Gustafsson. Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congential heart disease. Br. Heart J. 71: 282-286, 1994.
49. Zapol, W. M., and M. T. Snyder. Pulmonary artery hypertension in severe acute respiratory failure. N. Engl. J. Med. 296: 476-480, 1977.
50. Zayek, M., D. Cleveland, and F. C. Morin. Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. J. Pediatr. 122: 743-750, 1993.